Efficacy of Tricyclic Antidepressant Therapy in Adults With Cyclic Vomiting Syndrome: A Two-year Follow-up Study
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
AIM: To investigate the effects of prolonged tricyclic antidepressants (TCAs) therapy on the frequency and duration of episodes of cyclic vomiting syndrome (CVS) in adults, and the global assessment of clinical improvement and the number of emergency department (ED) visits and/or hospitalizations. METHOD: An open labeled study was conducted in adult CVS patients treated with a TCA and followed for up to 2 years. Demographic data, TCA dosage, duration and frequency of CVS episodes, ED visits, and hospitalizations at baseline and during TCA therapy were recorded, and patients were monitored for any adverse events. RESULTS: Forty-six patients initially met the inclusion criteria and 41 patients (22 male) with mean age of 35 years (range: 18 to 63 y) on TCA were able to be followed for 1 year and 23 were evaluated for 2 years. Mean age of onset of CVS symptoms was 26 years (range: 10 to 52 y) and mean age for making the diagnosis of CVS was 32 years (range: 15 to 63 y). The frequency and duration of an episode and ED visits related to CVS were all significantly reduced after both the first and second year of TCA therapy (P<0.05). Eighty-eight percent reported an improved clinical status by subjective global assessment. Mild side effects were reported in 34% not necessitating stoppage of the TCA. CONCLUSIONS: Long-term TCA therapy significantly reduces the frequency and duration of CVS episodes, ED visits, and hospitalizations (P<0.05), and improves overall clinical well-being providing evidence that they are effective therapy for adult CVS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The evidence on the use of TCAs in adults with CVS is based on open‐label and retrospective studies and two randomized controlled trials (RCTs) in children.”
In the citing paper
“Across these studies, 413/600 (70%) of patients reported complete or partial improvement with a decrease in frequency, duration, or severity of CVS symptoms when treated with a TCA, most commonly amitriptyline.”
In the citing paper
“There were fourteen studies that included 600 adult and pediatric patients.”
In the citing paper
“The mean effective dose in adults is 75‐100 mg daily or 1‐1.5 mg/kg body weight.”
In the citing paper
“The prevalence of migraine headaches in adults with CVS varies between 13% and 70%.15 75”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“The usual dose that was effective in these conditions, especially in FGID, is lower than the traditional antidepressant doses.(13,16) This finding is echoed in our study, as the median dose of 100mg/d is much lower than the doses used in the past for psychiatric indications.”
ResultOnghena, P., & Van Houdenhove, B. (1992) · Pain · doi:10.1016/0304-3959(92)90144-z · Cited by 563
Central neurocircuitry associated with emesis
Hornby, P. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00849-x · Cited by 432 · cited 1×
“This area of the brain receives input from the area postrema and abdominal vagus through the nucleus tractus solitarius.(20,21) Although the exact etiology of CVS is unknown, it could be possible that this area of the brain is activated by the various factors or ‘‘triggers’’ of CVS leading to manifestation of the vomi…”
BackgroundTrindade, E. M., Menon, D., Topfer, L.-A., & Coloma, C. (1998) · Europe PMC (PubMed Central) · Cited by 317
The Use of Antidepressants in the Treatment of Chronic Pain: A Review of the Current Evidence
Magni, G. (1991) · Drugs · doi:10.2165/00003495-199142050-00002 · Cited by 244
Cyclic Vomiting Syndrome in 41 adults: the illness, the patients, and problems of management
Fleisher, D. R., Gornowicz, B., Adams, K., Burch, R., & Feldman, E. J. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-20 · Cited by 215 · cited 9×
“There are little data on preventive treatment in adult CVS.4,7 Our recent report on the overall treatment experience in 24 patients who received amitriptyline for at least 3 months indicated that 93% had a favorable response with decreased frequency and severity of their symptoms and 26% achieved full remission.4 Prak…”
InfluentialCyclic vomiting syndrome in adults
Abell, T. L., Adams, K. A., Boles, R. G., Bousvaros, A., Chong, S. K. F., Fleisher, D. R., Hasler, W. L., Hyman, P. E., Issenman, R. M., Li, B. U. K., et al. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01113.x · Cited by 194 · cited 1×
“The patient population demographics are similar to the other published adult CVS cohorts in terms of male predominance (54%), personal or family history of migraine diathesis (36%), and marijuana use (53%).(4,5,7,18) Although 1 study had a female/male ratio of 1.”
MethodSelf-citationIs cyclic vomiting syndrome related to migraine?
Li, B. U. K., Murray, R. D., Heitlinger, L. A., Robbins, J. L., & Hayes, J. R. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70242-8 · Cited by 185 · cited 1×
“CVS was first described in the late 19th century and was essentially thought to be a disorder of childhood, but it is increasingly being recognized in adults over the last 20 years.(2) The diagnostic criteria for adult CVS according to the Rome III criteria are stereotypic episodes of vomiting with the following chara…”
BackgroundCyclic Vomiting Syndrome: Evolution in Our Understanding of a Brain-Gut Disorder
Li, B. U. K., & Balint, J. P. (2000) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00096-8 · Cited by 184 · cited 2×
“Cyclic vomiting syndrome (CVS) is a disease characterized by recurrent and stereotypic episodes of incapacitating nausea and vomiting interspersed with relatively symptom-free intervals that might last anywhere from a few weeks to months.(1) CVS was first described in the late 19th century and was essentially thought…”
BackgroundNamin, F., Patel, J., Lin, Z., Sarosiek, I., Foran, P., Esmaeili, P., & Mccallum, R. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00867.x · Cited by 129 · cited 5×
“There are little data on preventive treatment in adult CVS.(4,7) Our recent report on the overall treatment experience in 24 patients who received amitriptyline for at least 3 months indicated that 93% had a favorable response with decreased frequency and severity of their symptoms and 26% achieved full remission.”
BackgroundMethodInfluentialSelf-citation
Cited by
Cannabinoid Hyperemesis Syndrome
A. Galli, J., Andari Sawaya, R., & K. Friedenberg, F. (2011) · Current Drug Abuse Reviewse · doi:10.2174/1874473711104040241 · Cited by 303
“For example, in two recently published series of adult patients with CVS, approximately one third of patients reported daily marijuana use [65,66].”
BackgroundVenkatesan, T., Levinthal, D. J., Tarbell, S. E., Jaradeh, S. S., Hasler, W. L., Issenman, R. M., Adams, K. A., Sarosiek, I., Stave, C. D., Sharaf, R. N., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13604 · Cited by 137
Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome
Venkatesan, T., Levinthal, D. J., Li, B. U. K., Tarbell, S. E., Adams, K. A., Issenman, R. M., Sarosiek, I., Jaradeh, S. S., Sharaf, R., Sultan, S., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13606 · Cited by 173
“Conversely, another case series of patients with CVS with high proportions of cannabis users reported >80% response rates to tricyclic medications.(185) Moreover, Venkatesan et al.”
BackgroundLevetiracetam Mechanisms of Action: From Molecules to Systems
Contreras-García, I. J., Cárdenas-Rodríguez, N., Romo-Mancillas, A., Bandala, C., Zamudio, S. R., Gómez-Manzo, S., Hernández-Ochoa, B., Mendoza-Torreblanca, J. G., & Pichardo-Macías, L. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040475 · Cited by 131
“Clinical studies have shown in adult patients and elderly patients that LEV (initial dose was 500 mg/day and increased in 500 mg increments, n a twice daily dosing regimen, to a median dose of 1000 mg per day) is effective for prophylaxis against cyclic vomiting syndrome episodes [86,87].”
BackgroundPharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review
Richards, J. R., Gordon, B. K., Danielson, A. R., & Moulin, A. K. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1931 · Cited by 126
Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department
Richards, J. R. (2018) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2017.12.010 · Cited by 112
Kumar, N., Bashar, Q., Reddy, N., Sengupta, J., Ananthakrishnan, A., Schroeder, A., Hogan, W. J., & Venkatesan, T. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-52 · Cited by 96
“However, there was a high incidence of side effects associated with TCA therapy resulting in discontinuation in 26% of patients which limited its use [20].”
BackgroundVenkatesan, T., Prieto, T., Barboi, A., Li, B., Schroeder, A., Hogan, W., Ananthakrishnan, A., & Jaradeh, S. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01577.x · Cited by 95
Review article: cyclic vomiting syndrome in adults – rediscovering and redefining an old entity
Hejazi, R. A., & McCallum, R. W. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04721.x · Cited by 81
“In our experience, only 3–4% of patients actually had to stop using TCAs.(7) We then rely on other TCAs such as nortriptyline and doxepin as substitutes with less adverse events, but still with thera-”
BackgroundInfluentialSelf-citationHejazi, R. A., Lavenbarg, T. H., & Mccallum, R. W. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01584.x · Cited by 74
Self-citationYates, C., Galvão, T. F., Sowinski, K. M., Mardini, K., Botnaru, T., Gosselin, S., Hoffman, R. S., Nolin, T. D., Lavergne, V., Ghannoum, M., et al. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12227 · Cited by 58
The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome
Lee, C., Greene, S. L., & Wong, A. (2019) · Clinical Toxicology · doi:10.1080/15563650.2018.1564324 · Cited by 56
“Other therapeutics that have shown utility include benzodiazepines and TCAs as short- and long-term treatments, respectively [8,26,28].”
BackgroundWasilewski, A., Lewandowska, U., Mosińska, P., Watała, C. W., Storr, M., Fichna, J., & Venkatesan, T. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.73 · Cited by 56
Rubio‐Tapia, A., McCallum, R. W., & Camilleri, M. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.040 · Cited by 56
Self-citationCyclic vomiting syndrome: diagnostic approach and current management strategies
Hayes, W. J., Gilder, D. V., Berendse, J., Lemon, M., & Kappes, J. A. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s136420 · Cited by 55
“Efficacy of several TCAs was shown in an open label study of 41 adult patients who received amitriptyline (38 patients), nortriptyline (two patients), or doxepin (one patient) with up to 2 years of follow-up.(19) Patients met the Rome III criteria for CVS and questionnaires/interviews were completed at baseline and at…”
Cyclic vomiting syndrome: epidemiology, diagnosis, and treatment
Bhandari, S., Jha, P., Thakur, A., Kar, A., Gerdes, H., & Venkatesan, T. (2018) · Clinical Autonomic Research · doi:10.1007/s10286-018-0506-2 · Cited by 53
HEJAZI, R. A., LAVENBARG, T. H., FORAN, P., & MCCALLUM, R. W. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04165.x · Cited by 43
Self-citationChoung, R. S., Locke, G. R., Lee, R. M., Schleck, C. D., Zinsmeister, A. R., & Talley, N. J. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01791.x · Cited by 42
Park, J. W., Cho, Y.-S., Lee, S. Y., Kim, E.-S., Cho, H., Shin, H. E., Suh, G. I., & Choi, M.-G. (2013) · Gut and Liver · doi:10.5009/gnl.2013.7.6.668 · Cited by 39
“However, a recent study that involved larger numbers of adult CVS patients demonstrated that one in four adults have a history of migraine headaches.(32) In our study, a small percentage of migraine patients (8.”
BackgroundGajendran, M., Sifuentes, J., Bashashati, M., & McCallum, R. W. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001564 · Cited by 46
Self-citationCyclic Vomiting Syndrome and Abdominal Migraine in Adults and Children
Evans, R. W., & Whyte, C. A. (2013) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12124 · Cited by 39
“triptyline results in improvement in more than 80% with continued efficacy on 2-year follow up.(12,36) Carbamazepine, phenobarbital, valproic acid, gabapentin, zonisamide, and levetiracetam have been used particularly for those patients with CVS and abnor-”
BackgroundCyclic vomiting syndrome: treatment options
Hejazi, R. A., & McCallum, R. W. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-3989-7 · Cited by 38
Self-citationA Comprehensive Review and Update on Cannabis Hyperemesis Syndrome
Loganathan, P., Gajendran, M., & Goyal, H. (2024) · Pharmaceuticals · doi:10.3390/ph17111549 · Cited by 35
Migraine, Cyclic Vomiting Syndrome, and Other Gastrointestinal Disorders
Yu, E. S., Siddharthan, Y. P. S., & Venkatesan, T. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0202-2 · Cited by 31
Management of cyclic vomiting syndrome in adults: Evidence review
Sharaf, R., Venkatesan, T., Shah, R., Levinthal, D. J., Tarbell, S. E., Jaradeh, S. S., Hasler, W. L., Issenman, R. M., Adams, K. A., Sarosiek, I., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13605 · Cited by 54
Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review
McConachie, S. M., Caputo, R. A., Wilhelm, S. M., & Kale-Pradhan, P. B. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019852601 · Cited by 32
Cyclic vomiting syndrome in 28 patients: demographics, features and outcomes
Lee, L. Y., Abbott, L., Moodie, S. J., & Anderson, S. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328354fc83 · Cited by 27
Cyclic vomiting syndrome: a case series and review of the literature
Shearer, J., Luthra, P., & Ford, A. C. (2018) · Frontline Gastroenterology · doi:10.1136/flgastro-2016-100705 · Cited by 23
Rosen, S. N., Diaz, R., Garacci, E., Kumar, V. C. S., Thyarala, S. R., Hillard, C. J., & Venkatesan, T. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06343-x · Cited by 23
Bagherian, Z., Yaghini, O., Saneian, H., & Badihian, S. (2019) · Iranian journal of child neurology. · doi:10.22037/ijcn.v13i1.14385 · Cited by 26
“Amitriptyline is a tricyclic antidepressant (TCA) reported in previous studies (6, 14, 15) as one of the most effective treatments for CVS patients.”
BackgroundMcCallum, R. W. (2014) · Medical Science Monitor · doi:10.12659/msm.890547 · Cited by 23
Self-citationRetrospective review of patients treated for cyclic vomiting syndrome with topiramate
Mooers, H. M., Srivastava, S., Garacci, E., & Venkatesan, T. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16457 · Cited by 23
Karrento, K., Rosen, J. M., Tarbell, S. E., Issenman, R. M., Gelfand, A. A., Gamboa, H. E., Parikh, S., Adams, K. A., Wiercioch, W., & Li, B. U. K. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70020 · Cited by 26
Emerging strategies for the treatment of gastroparesis
Langworthy, J., Parkman, H. P., & Schey, R. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1150175 · Cited by 21
“Amitriptyline and Nortriptyline have been shown to improve symptoms in patients with cyclic vomiting syndrome, and chronic vomiting in diabetic patients [58,59].”
BackgroundNovel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline
Bhandari, S., & Venkatesan, T. (2016) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-016-0114-y · Cited by 23
Nasser, Y., Woo, M. M. K., & Andrews, C. N. (2020) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-020-00323-w · Cited by 20
Cannabis use patterns and association with hyperemesis: A comprehensive review
Hasler, W. L., Alshaarawy, O., & Venkatesan, T. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14895 · Cited by 23
“46 Furthermore, a multivariate comparison did not find that cannabis influenced responses to tricyclic drugs for CVS prophylaxis.”
Newest Drugs for Chronic Unexplained Nausea and Vomiting
Hasler, W. L. (2016) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-016-0110-2 · Cited by 19
Approach to the Patient with Nausea and Vomiting
Hasler, W. L. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch38 · Cited by 16
Cannabinoid hyperemesis syndrome: prevalence and management in an era of cannabis legalization
Stubbs, J. J., & McCallum, R. W. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231217495 · Cited by 15
Self-citationPartovi, O., Patel, M., Kovacic, K. K., Petrova, A., Garacchi, Z., & Venkatesan, T. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14571 · Cited by 14
Thavamani, A., Umapathi, K. K., Khatana, J., Bhandari, S., Kovacic, K. K., & Venkatesan, T. (2022) · Children · doi:10.3390/children9010055 · Cited by 14
Efficacy of aprepitant as a prophylactic medication in adults with cyclic vomiting syndrome
Patel, M., Partovi, O., Mooers, H. M., Kovacic, K. K., Garacchi, Z., & Venkatesan, T. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14530 · Cited by 14
Psychotropic Medications for Pediatric Functional Gastrointestinal Disorders
Hussain, S. Z., & Hyman, P. E. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000445 · Cited by 12
“Selective serotonin reuptake inhibitors (SSRIs) have transient but bothersome gastrointestinal adverse authorized reproduction of this article is prohibited. effects that may preclude their use for anxiety-associated nausea. axis including frontal lobe of the brain, arousal center, and ascending e gyrus; CRN ¼ caudal…”
BackgroundInfluentialCyclic vomiting syndrome: an overview for clinicians
Herlihy, J. D., Reddy, S. B., Shanker, A., & McCallum, R. W. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1691527 · Cited by 10
Self-citationCannabis use and cyclical vomiting syndrome: An open debate
Kilani, Y., Aljabiri, Y., ARSHAD, I., Alsakarneh, S., Aldiabat, M., Puelo, P. C., Vahanyan, A., Vikash, F., Kumar, V., Numan, L., et al. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.10.002 · Cited by 8
Haghighat, M., Memari, H., Honar, N., Dehghani, S. M., Imanieh, M. H., Injoo, S.-J., & Javaherizadeh, H. (2017) · Gastroenterology Review · doi:10.5114/pg.2017.72105 · Cited by 8
“Other side effects of TCAs are neurological complications (including hallucination, delirium, coma), constipation, and urinary retention [8].”
BackgroundInfluentialFrazier, R., & Venkatesan, T. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2138341 · Cited by 7
Pharmacogenomic testing for CYP2C19 and CYP2D6 in cyclic vomiting syndrome
Patel, M., Partovi, O., Karrento, K., Garacchi, Z., Balasubramanian, G., & Venkatesan, T. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14705 · Cited by 6
“6,15,16,26 There is also significant variation in rates of discontinuation of TCAs with none discontinuing AT in some studies to as high as 50% in others, which might reflect the patient population as well as variations in practice patterns in different centers.”
BackgroundButt, M. F., Cefalo, F., Sbarigia, C., Dhali, A., & Corsetti, M. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70007 · Cited by 5
“The therapeutic dose of TCA in the management of CVS has yet to be confirmed in randomized controlled trial settings but is reported to range between 75 and 100 mg daily [17, 18].”
InfluentialOnabotulinumtoxinA Injections for the Treatment of Cyclic Vomiting Syndrome
Hayes, W. J., Weisensee, L. A., Kappes, J. A., Dalton, S. M., & Lemon, M. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1570 · Cited by 5
“The most common ADRs reported with ONABoNT-A injections, when used for migraine headaches, include neck pain (9%), headaches (5%), worsening migraine (4%), muscular weakness (4%), and eyelid ptosis (4%).18 As discussed, CVS is hypothesized to be a variant of migraine and is often triggered by physical and/or psycholog…”
BackgroundInfluentialCyclic vomiting syndrome: From pathophysiology to treatment
Jiménez‐Castillo, R. A., Frazier, R., Venkatesan, T., & Remes-Troche, J. M. (2024) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2024.06.001 · Cited by 4
Gomez-Escudero, O., Remes-Troche, J. M., Coss-Adame, E., García‐Zermeño, K. R., Aquino-Matus, J. E., Pavón, J. J., Valdovinos-García, L. R., Vargas-Martínez, M. A., Amieva‐Balmori, M., Arenas-Martinez, J. S., et al. (2025) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.12.001 · Cited by 7
Use of a Once-Daily NSAID in Treatment of Cyclic Vomiting Syndrome
Vidula, M. K., Wadhwani, A. R., Roberts, K. F., & Berkowitz, L. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2624-9 · Cited by 4
Cyclic Vomiting Syndrome Developed after Stroke
Lee, K. L., & Shin, J. I. (2012) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2012.36.1.141 · Cited by 3
Cyclic vomiting syndrome in adults
Keller, K., Beule, J., & Dippold, W. G. (2013) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-013-0250-0 · Cited by 4
Time Trends in Healthcare Utilization Due to Self-Reported Functional Diseases of the Stomach
Bielefeldt, K. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06154-0 · Cited by 3
Modern concepts about cyclic vomiting syndrome in children
Varisova, A. K., Svirava, A. M., Дудникова, Э. В., Badyan, A. S., Алексеевна, Б. Е., & Чернова, М. С. (2024) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2024-69-2-117-126 · Cited by 2
Chen, Y. J., Patel, M., & Venkatesan, T. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14910 · Cited by 3
“13 Despite its efficacy, approximately 9%–25% of patients experience side effects which include daytime sedation, constipation, dryness of mouth, and weight gain.”
33-jähriger Patient mit stereotypen Erbrechensepisoden seit 11 Jahren
Keller, K., Beule, J., & Dippold, W. G. (2011) · Der Internist · doi:10.1007/s00108-011-2962-9 · Cited by 2
Antiemetic therapy for gastroparesis
Wo, J. M., McCallum, R. W., & Gonzalez, Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818586-5.00025-9 · Cited by 4
Self-citationCyclic vomiting syndrome : Future clinical and research priorities
Hasler, W. L., Li, B. U. K., Levinthal, D. J., & Venkatesan, T. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14825 · Cited by 2
“11,12 In 2019, comprehensive adult guidelines based on GRADE methodology rather than expert consensus laid the foundation for standardizing management of CVS based on evidence.”
Zyklisches Erbrechens-Syndrom beim Erwachsenen: Kasuistik über 5 Patienten
Keller, K., Beule, J., Scholz, M. B. D. S., Pfnür, M., & Dippold, W. G. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Management of cannabinoid hyperemesis syndrome—is it more than just avoiding cannabis use?
Kaiser, S. K., & Monte, A. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821597-5.00002-2 · Cited by 1
Cyclic Vomiting Syndrome Versus Cannabinoid Hyperemesis Syndrome
Singh, B., Grover, P., & Kaur, G. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm25033 · Cited by 1
“For prophylactic treatment, anti-epileptics, most notably ami-triptyline, 6 which Hejazi et al 7 demonstrated an improvement in the number of CVS episodes, and Topiramate in studies has shown 81% remission.”
Diagnosis and Treatment of Functional Nausea and Vomiting
Shin, J. E. (2012) · Korean Journal of Medicine · doi:10.3904/kjm.2012.82.5.543 · Cited by 1
“부작용을 호소하지만 대부분 별 문제없이 사용할 수 있다 [13].”
Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis Syndrome
Kingsley, M. J., & Levinthal, D. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-01117-8_4 · Cited by 1
Editorial: topiramate for cyclic vomiting syndrome—for refractory patients only?
Rangan, V., & Lembo, A. J. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16493 · Cited by 1
Cyclic vomiting syndrome treated successfully with fluoxetin
Altun, H., Gül, Ö., Öksüz, A. N., & Şahın, N. (2017) · Türk Pediatri Arşivi · doi:10.5152/tpa.2014.1373
“In the literature, there is no study related with use of fluoxetine in treatment of CVS.”
BackgroundInfluentialDang-Vu, G., & Venkatesan, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-59352-4_23
Cyclic Vomiting Syndrome: Does Gender Matter? How Does It Affect the Health of Women?
Kumar, V. C. S., & Venkatesan, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-25626-5_4
Prevention of recurrent cyclic vomiting syndrome episodes
Levinthal, D. J., Hasler, W. L., & Venkatesan, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821597-5.00014-9
Cyclic vomiting syndrome health experiences among patients and their caregivers
Adams, K. A., & Jensen, A. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821597-5.00010-1
How common is cannabinoid hyperemesis syndrome and why is it so hard to diagnose?
Harer, K. N., & Hasler, W. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821597-5.00004-6
Clinical features of cyclic vomiting syndrome
Kamal, A. N., Kovacic, K. K., & Li, B. U. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821597-5.00007-1
Cyclic vomiting syndrome and cannabinoid hyperemesis syndrome
Tansel, A., & Levinthal, D. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13911-6.00019-0
AlHussaini, K. I. (2023) · Cureus · doi:10.7759/cureus.43249
“The use of amitriptyline in adults with CVS was linked to a reduction in emergency department visits and hospitalizations [15].”
BackgroundMustaffa, N., Rasul, S. F. G., Draman, N., Jamani, N. A., & Yudin, Z. M. (2023) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v22i4.2155
Síndrome de vómitos cíclicos: de la fisiopatología al tratamiento
Jiménez‐Castillo, R. A., Frazier, R., Venkatesan, T., & Remes-Troche, J. M. (2024) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.06.001 · Cited by 1
Gomez-Escudero, O., Remes-Troche, J. M., Coss-Adame, E., García‐Zermeño, K. R., Aquino-Matus, J. E., Pavón, J. J., Valdovinos-García, L. R., Vargas-Martínez, M. A., Amieva‐Balmori, M., Arenas-Martinez, J. S., et al. (2025) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2024.12.001 · Cited by 3
Cannabis Hyperemesis or Cyclic Vomiting- A Comparative Literature ReviewPreprint
Singh, B., Grover, P., & Kaur, G. (2025) · Preprints.org · doi:10.20944/preprints202507.1484.v1
Les syndromes épisodiques pouvant être associés à la migraine de l’enfant
Tourniaire, B. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0235-0_8
Management of Cannabinoid Hyperemesis Syndrome in Adolescents and Young Adults
Nguyen, N., Bravender, T. D., & Goldman, P. N. (2025) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2025.114966
Managing Cannabinoid Hyperemesis Syndrome
Rech, M. A., Shalaby, M., Gage, K. A., & Gottlieb, M. A. (2026) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2025.12.024
Cyclic vomiting syndrome and abdominal pain
Ayyan, M., Srivastava, S., Binienda, A., & Venkatesan, T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41638-5.00008-9
Metadata
- Authors
- Hejazi, R. A., Reddymasu, S. C., Namin, F., Lavenbarg, T., Foran, P., & McCallum, R. W.
- Affiliations
- University of Kansas Medical Center (US)
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-01
- Volume
- 44
- Issue
- 1
- Pages
- 18-21
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2015299208
- Cited by
- 84
- References
- 24
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 2 · 2020: 5 · 2019: 9 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 5
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- cyclic vomiting syndrome, tricyclic antidepressants, adult patients, emergency department visits, hospitalization, adverse drug reactions, Subjective Global Assessment
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Tricyclic, Dose-Response Relationship, Drug, Emergency Service, Hospital, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Periodicity, Severity of Illness Index, Syndrome, Time Factors, Vomiting, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.